Polymorphisms in the presumptive promoter region of the slc2a9 gene are associated with gout in a chinese male population

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Li, Changgui ^a   Chu, Nan ^a   Wang, Binbin ^b,c   Wang, Jing ^b,c   Luan, Jian ^d   Han, Lin ^a   Meng, Dongmei ^a   Wang, Yunlong ^a   Suo, Peisu ^b,c   Cheng, Longfei ^b,c   Ma, Xu ^b,c,e   Miao, Zhimin ^a   Liu, Shiguo ^a  

^a QINGDAO UNIVERSITY   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^c NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^d QINGDAO MUNICIPAL HOSPITAL   (China)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; TRIACYLGLYCEROL; GLUCOSE TRANSPORTER; SLC2A9 PROTEIN, HUMAN;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CHINESE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; EXON; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GOUT; HAPLOTYPE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PREDICTION; PROMOTER REGION; PROTEIN BINDING; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A9 GENE; AGED; ALLELE; CHINA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INFLAMMATION; MIDDLE AGED; PHENOTYPE;

ADULT; AGED; ALLELES; CHINA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GOUT; HAPLOTYPES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84863234547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024561     Document Type: Article

References (38)

1. Miao Z, Li C, Chen Y, Zhao S, Wang Y, et al. (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35: 1859-1864.
2. Choi HK, Mount DB, Reginato AM, (2005) Pathogenesis of gout. Ann Intern Med 143: 499-516.
3. Choi HK, Ford ES, Li C, Curhan G, (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57: 109-115.
4. Choi HK, De Vera MA, Krishnan E, (2008) Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford) 47: 1567-1570.
5. Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, et al. (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1301-1311.
6. Terkeltaub R, Bushinsky DA, Becker MA, (2006) Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther 8 (Suppl 1): S4.
7. Terkeltaub RA, (2003) Clinical practice. Gout. N Engl J Med 349: 1647-1655.
8. Dalbeth N, Merriman T, (2009) Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. Rheumatology (Oxford) 48: 222-226.
9. Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, et al. (2008) SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5: e197.
10. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, et al. (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40: 437-442.
11. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, et al. (2008) SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40: 430-436.
12. Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, et al. (2004) Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 279: 16229-16236.
13. Richardson S, Neama G, Phillips T, Bell S, Carter SD, et al. (2003) Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation. Osteoarthritis Cartilage 11: 92-101.
14. Matsuo H, Chiba T, Nagamori S, Nakayama A, Domoto H, et al. (2008) Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 83: 744-751.
15. Dinour D, Gray NK, Campbell S, Shu X, Sawyer L, et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol 21: 64-72.
16. McArdle PF, Parsa A, Chang YP, Weir MR, O'Connell JR, et al. (2008) Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. Arthritis Rheum 58: 2874-2881.
17. Li S, Sanna S, Maschio A, Busonero F, Usala G, et al. (2007) The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 3: e194.
18. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, et al. (2008) Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82: 139-149.
19. Brandstatter A, Kiechl S, Kollerits B, Hunt SC, Heid IM, et al. (2008) Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 31: 1662-1667.
20. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, et al. (2008) Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372: 1953-1961.
21. Zemunik T, Boban M, Lauc G, Jankovic S, Rotim K, et al. (2009) Genome-wide association study of biochemical traits in Korcula Island, Croatia. Croat Med J 50: 23-33.
22. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, et al. (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5: e1000504.
23. Brandstatter A, Lamina C, Kiechl S, Hunt SC, Coassin S, et al. (2009) Sex and age interaction with genetic association of atherogenic uric acid concentrations. Atherosclerosis 210: 474-478.
24. Cummings N, Dyer TD, Kotea N, Kowlessur S, Chitson P, et al. (2010) Genome-wide scan identifies a quantitative trait locus at 4p15.3 for serum urate. Eur J Hum Genet 18: 1243-1247.
25. Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, et al. (2008) Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS One 3: e1948.
26. Tu HP, Chen CJ, Tovosia S, Ko AM, Lee CH, et al. Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders. Ann Rheum Dis 69: 887-890.
27. Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, et al. (2009) Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum 60: 3485-3492.
28. Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, et al. (2009) Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One 4: e7729.
29. Polasek O, Gunjaca G, Kolcic I, Zgaga L, Dzijan S, et al. (2010) Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients. Croat Med J 51: 48-53.
30. Urano W, Taniguchi A, Anzai N, Inoue E, Sekita C, et al. (2010) Association between GLUT9 and gout in Japanese men. Ann Rheum Dis 69: 932-933.
31. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, et al. (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20: 895-900.
32. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
33. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, et al. (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 64: 267-272.
34. Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, et al. (2008) Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem 283: 26834-26838.
35. Bibert S, Hess SK, Firsov D, Thorens B, Geering K, et al. (2009) Mouse GLUT9: evidences for a urate uniporter. Am J Physiol Renal Physiol 297: F612-619.
36. Schumacher HR Jr, Becker MA, Palo WA, Streit J, MacDonald PA, et al. (2005) Tophaceous gout: quantitative evaluation by direct physical measurement. J Rheumatol 32: 2368-2372.
37. Mobasheri A, Neama G, Bell S, Richardson S, Carter SD, (2002) Human articular chondrocytes express three facilitative glucose transporter isoforms: GLUT1, GLUT3 and GLUT9. Cell Biol Int 26: 297-300.
38. Doege H, Bocianski A, Joost HG, Schurmann A, (2000) Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 350 Pt 3: 771-776.